|
HERC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
2.01350047746018E-11 |
| Normal-vs-Stage3 |
1.11022302462516E-16 |
| Normal-vs-Stage4 |
1.62470037423645E-12 |
| Stage1-vs-Stage2 |
2.477600E-01 |
| Stage1-vs-Stage3 |
3.282300E-02 |
| Stage1-vs-Stage4 |
3.489600E-02 |
| Stage2-vs-Stage3 |
2.947700E-02 |
| Stage2-vs-Stage4 |
1.768350E-02 |
| Stage3-vs-Stage4 |
4.316800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
3.5783999996486E-07 |
| Normal-vs-Asian |
3.29880567306873E-12 |
| Caucasian-vs-AfricanAmerican |
2.235600E-01 |
| Caucasian-vs-Asian |
9.010500E-02 |
| AfricanAmerican-vs-Asian |
7.764400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.380600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
1.12190000001178E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.818600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.926430E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.364400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.166200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.157600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.825400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.18689996614552E-09 |
| Classical-VS-Follicular |
1.882100E-03 |
| Classical-VS-Other |
5.536200E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
1.1678435996032E-12 |
| Tall-VS-Other |
1.285710E-02 |
| Tall-VS-Normal |
1.62436730732907E-12 |
| Follicular-VS-Other |
1.111030E-01 |
| Follicular-VS-Normal |
2.12874162741628E-12 |
| Other-VS-Normal |
1.0544999995421E-07 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.34114941374719E-13 |
| N0-vs-N1 |
2.199600E-01 |
|
|
